Physician profile
Robert John Wagner
NPI 1164419081
$1,817.20
in general payments reported to CMS, 2019-2025
22 companies · $95.05 in 2025
The $95.05 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.85 · 2020: $230 · 2021: $244 · 2022: $569 · 2023: $147 · 2024: $502 · 2025: $95.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $463.51 | 2019-2024 | Eluvia, Jetstream Sc |
| Philips North America LLC | $401.32 | 2020-2024 | (Bs1) Peripheral Vascular Undivided, (6577) Visions 014 |
| Edwards Lifesciences Corporation | $189.00 | 2024 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $119.94 | 2019-2024 | Xarelto |
| Bard Peripheral Vascular, INC. | $91.82 | 2020-2024 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Cook Medical LLC | $65.66 | 2021-2024 | Zilver Ptx, Zilver Vena |
| Terumo Medical Corporation | $59.94 | 2022-2024 | Angio-Seal, Navicross |
| Medtronic, INC. | $53.30 | 2021-2022 | |
| Kci USA, INC. | $49.38 | 2020 | |
| Cardiovascular Systems INC. | $40.98 | 2020-2022 | |
| Tactile Systems Technology INC | $38.94 | 2020-2021 | |
| Cashflow Solutions, LLC | $37.47 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Smith+Nephew, INC. | $35.65 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.61 | 2025 | |
| Pfizer INC. | $22.56 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.00 | 2021 | |
| Becton, Dickinson and Company | $21.54 | 2024 | Pristine |
| Cordis US Corp. | $19.21 | 2023 | Rain Sheath Transradial |
| Astrazeneca Pharmaceuticals LP | $17.38 | 2025 | Farxiga |
| Lilly USA, LLC | $16.54 | 2025 | Mounjaro |
| Seqirus USA INC | $15.96 | 2025 | Fluad, Flucelvax |
| Angiodynamics, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.